KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $5.1 million.

  • Fulgent Genetics' Free Cash Flow rose 11442.96% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.8 million, marking a year-over-year increase of 3076.25%. This contributed to the annual value of -$19.3 million for FY2024, which is 50148.04% down from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Free Cash Flow is $5.1 million, which was up 11442.96% from -$37.0 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Free Cash Flow ranged from a high of $221.7 million in Q1 2021 and a low of -$37.0 million during Q2 2025
  • For the 5-year period, Fulgent Genetics' Free Cash Flow averaged around $36.5 million, with its median value being $7.9 million (2022).
  • In the last 5 years, Fulgent Genetics' Free Cash Flow skyrocketed by 3879245.61% in 2021 and then tumbled by 75913.11% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Free Cash Flow stood at $71.1 million in 2021, then plummeted by 59.94% to $28.5 million in 2022, then tumbled by 58.48% to $11.8 million in 2023, then surged by 79.59% to $21.2 million in 2024, then plummeted by 76.19% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q3 2025, -$37.0 million for Q2 2025, and -$9.1 million during Q1 2025.